Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 5,558,537 | 5,775,504 | 5,989,047 | 8,449,631 | 8,450,064 | 34,222,783 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | 0 | |||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | 0 | |||||
| 4 | Total. Add lines 1 through 3 | 5,558,537 | 5,775,504 | 5,989,047 | 8,449,631 | 8,450,064 | 34,222,783 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | 14,561,195 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 19,661,588 | |||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 5,558,537 | 5,775,504 | 5,989,047 | 8,449,631 | 8,450,064 | 34,222,783 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 14,534 | 11,635 | 69,969 | 273,967 | 257,033 | 627,138 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | 2,101 | 1,060 | 691 | 234 | 2 | 4,088 |
| 11 | Total support. Add lines 7 through 10 | 34,854,009 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2015 | (b) 2016 | (c) 2017 | (d) 2018 | (e) 2019 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by .035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | ||
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
||
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | ||
| 4 Amounts paid to acquire exempt-use assets | ||
| 5 Qualified set-aside amounts (prior IRS approval required) | ||
| 6 Other distributions (describe in Part VI). See instructions | ||
| 7Total annual distributions. Add lines 1 through 6. | ||
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
||
| 9 Distributable amount for 2019 from Section C, line 6 | ||
| 10 Line 8 amount divided by Line 9 amount | ||
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2019 |
(iii) Distributable Amount for 2019 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2019 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2019 (reasonable cause required-- explain in Part VI). See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2019: | ||||
| a From 2014....... | ||||
| b From 2015....... | ||||
| c From 2016....... | ||||
| d From 2017....... | ||||
| e From 2018....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2019 distributable amount | ||||
|
i
Carryover from 2014 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from 3f. | ||||
| 4Distributions for 2019 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2019 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from 4. | ||||
|
5
Remaining underdistributions for years prior to 2019, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2019. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2020. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2015..... | ||||
| b Excess from 2016..... | ||||
| c Excess from 2017..... | ||||
| d Excess from 2018..... | ||||
| e Excess from 2019..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|---|
| SCHEDULE A, PART II, SECTION A | THE ORGANIZATION CHANGED THEIR ACCOUNTING YEAR END FROM DECEMBER 31(CALENDAR YEAR) TO JUNE 30 (FISCAL YEAR) IN 2015. IN ACCORDANCE WITH THE INSTRUCTIONS, THE COLUMNS FOR YEARS 2015-2019 CORRESPOND TO THE 5 PRIOR TAX RETURNS FILED: 2015 = 2015 RETURN (6/30/2016 YEAR-END) 2016 = 2016 RETURN (6/30/2017 YEAR-END) 2017 = 2017 RETURN (6/30/2018 YEAR-END) 2018 = 2018 RETURN (6/30/2019 YEAR-END) 2019 = 2019 RETURN (6/30/2020 YEAR-END) |
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| CONTINUED FROM FORM 990, PART III, LINE 4A: | and other disease awareness and education programs. During the fiscal year, the PFF accepted 14 new PFF Ambassadors into the programs. These Ambassadors consist of pulmonary fibrosis patients, caregivers, lung transplant recipients, and those who lost a loved one to the disease. PFF Ambassadors spoke at 34 in-person events including Support Group meetings, educational conferences and fundraisers and had over a dozen virtual opportunities as society shifted during COVID-19. The PFF Daughters Program was founded to expand awareness of pulmonary fibrosis, especially among policymakers, via grassroots events and fundraisers across the nation, in order to generate a broader understanding of the impact the disease has on those living with PF and their families. The PFF Daughters program is now the PFF Advocates, with more than 1,000 members. Pulmonary Fibrosis Awareness Month (September) is when the PF community unites as a collective voice to enhance disease awareness and provide outreach to those in need. During Pulmonary Fibrosis Awareness Month, the PF community joined the PFF and participated in the #BlueUp4PF campaign, attended educational events, hosted Team PFF fundraising events, participated in webinars and spread disease awareness through social media. More Than A Cough Campaign: In September 2019, the Pulmonary Fibrosis Foundation (PFF) and Three Lakes Foundation (TLF) joined forces to launch a new partnership to combat PF. The "More Than A Cough" (MTAC) campaign was created to drive public awareness of pulmonary fibrosis (PF) and was a key piece of this effort. The innovative multi-channel MTAC campaign, which ran through April 2020, featured two animated characters, Norm and Jennifer, designed to illustrate the experiences of patients and caregivers. They were introduced via digital, social media, broadcast, and print advertisements in Chicago followed by a Google campaign in the test markets of Birmingham, Scottsdale, and Nashville. MTAC produced over 62 million impressions, 432,000 visitors to the MTAC landing page, and 53,000 downloads of the pulmonary fibrosis risk list. The campaign achieved a 576% increase in the search term "pulmonary fibrosis" in Chicago alone. |
| CONTINUED FROM FORM 990, PART III, LINE 4B: | independently managed by a data coordinating center. The Registry also collects biological specimens that patients have agreed to give, which are deidentified and independently managed by a medical specimen storage facility associated with the data coordinating center. The Registrys key aims are to: (1) conduct benchmarking and quality improvement efforts across the PFFs medical center network; (2) develop a more representative understanding of PF patient in the United States; (3) facilitate research in identified priority areas; and (4) increase the PFFs reach within the PF community. As of June 30, 2020, the Registry has activated 42 sites and identified 2,003 patients for enrollment. This vital program is completing its first phase and will embark on the next phase to continue to capture clinical patient information and expand into the community to collect information from other patients, lung transplant recipients, caregivers, and families. This will provide a more representative understanding of the PF community and create a robust pool of engaged community members for advocacy, clinical trials, and other research. To learn more about the PFF Patient Registry, please go to: http://bit.ly/pffregistry. |
| CONTINUED FROM FORM 990, PART III, LINE 4C: | The PFF Summit features an innovative continuing medical education (CME) program for Health Care Professionals and sessions for PF patients and caregivers that address their growing educational needs. (Note: Some expenses for the PFF Summit 2019 were included in the 2018 Form 990). |
| FORM 990, PART III, LINE 4D: | 1. Marketing: Activities were first concentrated during September, October, and November to leverage exposure offered by Pulmonary Fibrosis Awareness Month (September) and through the PFF Summit (November). In January, we commissioned a first of its kind national survey to measure public awareness of PF. The online survey was administered to 2,103 adults nationwide and we found that 86% of Americans do not know the symptoms of PF. The survey announcement was followed by a satellite media tour with TV and radio stations across the U.S. to drive awareness of PF. On Feb. 27, Dr. Cosgrove conducted 20 interviews with television and radio stations across the country. Using Rare Disease Awareness Week as a story driver, he described the symptoms and risk factors of PF and encouraged the audience to visit AboutPF.org or discuss the disease with their physician. We also recorded and distributed an audio news release to radio stations nationwide. These activities overall continued to increase awareness of PF and its risk factors nationwide, generating more than 515.1 million impressions and successfully grew traffic to the AboutPF.org microsite and to the PFF's website, pulmonaryfibroisis.org. Inquiries to the PFF's Patient Communication Center (PCC) also grew as a result of the campaign. Constituencies served by the marketing campaign extension in traditional and digital media included patients and potential patients; caregivers and families; healthcare providers; at-risk populations. 2. Education: The Pulmonary Fibrosis Foundation (PFF) is committed to providing quality disease education to the pulmonary fibrosis community. The PFF strives to provide patients, caregivers, family members, and health care providers with the resources necessary to more fully understand PF, and to provide patients with the tools necessary to live with the disease and improve their quality of life. The Foundation created a variety of new materials and resources for the PF community in fiscal year 2019-2020. Printed materials included the PF Family and Friends Postcards. The PFF Oxygen Basics Booklet was translated to Spanish. The following materials were updated to include new PFF resources and reflect new treatment information due to medication label expansions: Pulmonary Fibrosis Information Guide (and translations), ILD Nursing and Allied Health Guide, Nintedanib Fact Sheet, Pirfenidone Fact Sheet, Scleroderma-Associated ILD Fact Sheet, PF Clinical Trial Postcard, and About PFF Brochure. Printed educational materials are distributed through the PFF Patient Communication Center and at education events and conferences. The PFF developed guidance and FAQ documents about COVID-19 and curated a list of relevant resources related to COVID-19 to provide reliable information about the pandemic to members of the PF community. The PFF also produced two videos about COVID-19 titled "PFF COVID-19 Guidance"COVID-19 Everyday Precautions." The PFF added a new patient story video to the Life with Pulmonary Fibrosis series in English and Spanish. Additionally, the PFF produced a new series of short videos titled "Words of Wisdom" which provides perspectives and advice from caregivers in the PF community. These videos can be found on the Foundation's YouTube channel. The PFF Disease Education Webinar Series engages the PF community in an online webinar discussion where they learn from, connect with, and pose questions to leading pulmonary fibrosis specialists each month. Ten webinars were presented in fiscal year 2019-20 and all can be viewed on the PFF website at https://bit.ly/pffwebinars and on the Foundation's YouTube channel. Topics addressed during this time period include idiopathic interstitial lung diseases, supplemental oxygen, treatment options, PF research, occupational PF, and COVID-19. |
| 3. PFF Care Center Network | The Pulmonary Fibrosis Foundation (PFF) is dedicated to promoting earlier recognition and diagnosis of pulmonary fibrosis and ensuring that patients receive the highest quality healthcare. As part of that commitment, over the past three years the PFF has worked with the PF medical community to establish the PFF Care Center Network (CCN), where people with PF can find experienced medical professionals who understand their disease and support services to improve the quality of their lives. The goals of the PFF CCN is to deliver state of the art, patient-centered care; to disseminate education to support our patients, caregivers and providers; to give voice to the needs of our community through advocacy and fundraising; and to accelerate research in PF both directly and through collaborations and networking. The CCNs programmatic service accomplishments are highlighted below. The PFF Medical team has developed a new PFF CCN Annual Report to all 68 care centers. This center based report will have a strong emphasis on benchmarking, research, clinical care, community-based clinical support, and patient satisfaction. We anticipate that with this data centric approach we will be better positioned to understand the unique characteristics within our network. The Palliative Care Services in Care Centers Survey working group strived for 100% Care Center participation with an estimated 136 survey responses. The aim of this survey is to understand the role of palliative care services, perspectives and current resources available to providers who care for patients with pulmonary fibrosis and interstitial lung disease. The survey was disseminated to physicians, advance practice providers, nurses, respiratory therapists, and social workers who care for ILD patients at the 68 PFF Care Centers. Interstitial lung disease (ILD) causes a profound symptom burden and carries a high mortality. Palliative care is dedicated to improving quality of life and empowering patients in advance care planning. Early integration of Palliative Care in ILD improves the rates of advance care planning and symptomatic management. Knowledge of ILD provider perspectives on Palliative Care is key to improving care delivery to ILD patients. Descriptive statistics will be compiled for survey responses in the next fiscal year. The Survey for PFF Care Centers During the 2020 COVID-19 Pandemic was conducted by the PFF Care Center Network. The purpose of this survey is to gather center based information on the impact of the coronavirus disease (COVID-19) by developing functioning strategies for clinical trial networks in the event of the next surge or other event making physical visits not possible. The results from this survey will only be used for academic research in order to allow the PFF to move health initiatives and advocacy recommendations measures forward. Key research initiatives such as these we will make an impact in promoting earlier recognition and diagnosis of pulmonary fibrosis and ensuring that patients receive the highest quality healthcare. 4. Advocacy: During the year, the PFF engaged policymakers in advocating for increased funding for pulmonary fibrosis research and improved access to oxygen for patients. The PFF hosted a virtual Hill Day in March to allow constituents to speak with their members of Congress about the impact of pulmonary fibrosis in their lives and the need for research funding. The PFF successfully asked the Centers for Medicare and Medicaid Services to waive the in-person testing requirements for oxygen certification during the public health emergency caused by COVID-19. The PFF provided training to grassroots advocates on meeting with their lawmakers to advocate for the needs of the community. |
| 5. Research Grants | The Pulmonary Fibrosis Foundation (PFF) places enormous importance on creating an environment that will assist in the development of effective treatments for pulmonary fibrosis (PF). The PFF Scholars Program supports projects that offer a high likelihood of improving the understanding of PF in the following research areas: basic science, translational, clinical, epidemiological, and health services. The goal of the PFF Scholars Program is to support emerging investigators to advance research that could translate into successful therapies, while also enabling these promising researchers to obtain dependent funding and continue their cutting-edge research. The Research Review Committee administers the peer-reviewed process, which funds six $50,000 grants per cycle. The PFF also considers other smaller grants that fit the research guidelines. 6. Support Groups: The PFF Support Group Leader Network provides a forum for PF support group leaders to connect, exchange ideas, and share best practices. The PFFs Support Group Network consists of over 140 support groups across the country. During the public health emergency caused by COVID-19, many groups have been meeting virtually, with support from the PFF. Online Support Group communities are a great way for patients, caregivers, family members, and friends to virtually connect for support and information. For those who are unable to attend an in-person group, or simply want additional interactions between meetings, the Pulmonary Fibrosis Foundation offers two telephone-based support groups: PFF Voices and Caring Conversations. In addition, the PFF has added Coloquio, a Spanish-language telephone support group. These groups meet once per month over the phone in a conference call setting. Each monthly meeting provides a chance to discuss different topics related to pulmonary fibrosis, share personal stories, ask questions and provide support to one another. Visit http://bit.ly/pffsupport to learn more. 7. PFF Patient Communication Center (PCC): The PFF Patient Communication Center (PCC) serves as the central information hub for pulmonary fibrosis patients, caregivers, the Support Group Leader Network (see Support Group section), and health care professionals. The PCC staff provides general information about pulmonary fibrosis that is tailored to individuals needs and answers questions about the availability of support services and other essential resources. Resources available include: information on PFF programs, educational and advocacy materials, how to find medical care and support groups, access to support services, information about available treatments, and how to find clinical trials. The Foundation continuously surveys the PF community to determine additional educational materials or translations of current materials that are needed and works to develop those materials to fit unmet needs in the community. The Foundation also facilitates physician education by providing materials through the Patient Communication Center and at educational conferences. The Foundation maintains an Oxygen Information Line to provide patients and caregivers with general information on accessing and safely using supplemental oxygen. In fiscal year 2019-2020, the Patient Communication Center received 4,647 inquiries via telephone and email. |
| FORM 990, PART VI, SECTION B, LINE 11B: | A COPY OF FORM 990 IS REVIEWED BY THE FINANCE COMMITTEE BEFORE FILING. THE FORM 990 IS AVAILABLE TO ALL BOARD MEMBERS BEFORE FILING THE FORM. |
| FORM 990, PART VI, SECTION B, LINE 12C: | THE ORGANIZATION HAS A CONFLICT OF INTEREST POLICY WITHIN THE EMPLOYEE HANDBOOK AND ALL EMPLOYEES ARE REQUIRED TO ADHERE TO THE POLICY. EMPLOYEES SIGN A DISCLOSURE FORM EACH YEAR. ANNUALLY, BOARD MEMBERS ARE SENT A FORM TO FILL OUT STATING WHETHER THEY HAVE ANY CONFLICTS OF INTEREST. IF SUCH CONFLICTS EXIST, THEN THEY FILL OUT AN ADDITIONAL FORM OUTLINING THOSE CONFLICTS. THE EXECUTIVE COMMITTEE REVIEWS ANY CONFLICTS THAT ARISE. |
| FORM 990, PART VI, SECTION B, LINES 15A & B: | CHIEF EXECUTIVE OFFICER AND CHIEF OPERATING OFFICER'S COMPENSATION WAS APPROVED BY THE EXECUTIVE COMMITTEE, WHICH SERVES AS THE COMPENSATION COMMITTEE. THIS APPROVAL WAS BASED ON A REVIEW BY AN INDEPENDENT COMPENSATION CONSULTANT AND IS SUPPORTED BY A WRITTEN EMPLOYMENT CONTRACT. THE COMMITTEE ALSO REVIEWED COMPENSATION SURVEYS AND FORM 990S OF OTHER ORGANIZATIONS TO ENSURE THE COMPENSATION WAS APPROPRIATE. THE SALARY FOR THE CHIEF MARKETING OFFICER WAS NOT REVIEWED BY THE COMPENSATION COMMITTEE, BUT THE SALARY WAS IN LINE WITH THE MARKET. |
| FORM 990, PART VI, SECTION C, LINE 19: | THE ORGANIZATION MAKES ITS FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST AND ON THE ORGANIZATION'S WEBSITE. THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE TO THE PUBLIC. |
| FORM 990 PART IX LINE 11G | DESCRIPTION:MARKETING CONSULTING TOTAL FEES:2290214 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:SITE PAYMENTS TOTAL FEES:894926 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:REGISTRY DCC CONSULTING TOTAL FEES:340612 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:OTHER CONSULTING TOTAL FEES:335191 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:MEDICAL CONSULTING TOTAL FEES:322143 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:REGISTRY CONSULTING TOTAL FEES:166965 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:CME TOTAL FEES:72250 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:RECRUITMENT FEES TOTAL FEES:54665 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:MERCHANT CARD CHARGES TOTAL FEES:48980 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:STIPENDS TOTAL FEES:22625 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:INVESTMENT FEES TOTAL FEES:21776 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:MEDIA RELATIONS TOTAL FEES:19685 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:COLLECTION KIT TOTAL FEES:19650 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:GRAPHIC DESIGN TOTAL FEES:19500 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:IT CONSULTING TOTAL FEES:15897 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:EMPLOYEE ADMINISTRATION FEES TOTAL FEES:13496 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:OTHER OUTSIDE SERVICES TOTAL FEES:13160 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:WRITING/EDITING TOTAL FEES:3660 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:PHOTOGRAPHY TOTAL FEES:2240 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:REGISTRY HRCT CONSULTING TOTAL FEES:-6989 |
| Software ID: | |
| Software Version: |